Gabather AB (GABA)

Sell: 0.0284 SEK|Buy: 0.0318 SEK|Change: 0 (0%)

Open

0.0318 SEK

Previous close

0.0318 SEK

Trade high

0.0318 SEK

Volume

233,323

Year high

2.39943 SEK

Year low

0.025 SEK

Dividend yield

–

Market capitalisation

7.51 mn SEK

P/E ratio

0.16

ISIN

SE0010869552

This share can be held in a Dealing account SIPP

Share price

Performance 23/12/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Gabather AB	0.00
More...

Company profile

Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.

Sector

Healthcare

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.